Fujinaga K - Search Results

1

Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus.

Barboric M, Taube R, Nekrep N, Fujinaga K, Peterlin BM. Barboric M, et al. Among authors: fujinaga k. J Virol. 2000 Jul;74(13):6039-44. doi: 10.1128/jvi.74.13.6039-6044.2000. J Virol. 2000. PMID: 10846086 Free PMC article.

2

The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.

Cujec TP, Okamoto H, Fujinaga K, Meyer J, Chamberlin H, Morgan DO, Peterlin BM. Cujec TP, et al. Among authors: fujinaga k. Genes Dev. 1997 Oct 15;11(20):2645-57. doi: 10.1101/gad.11.20.2645. Genes Dev. 1997. PMID: 9334327 Free PMC article.

3

The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.

Fujinaga K, Cujec TP, Peng J, Garriga J, Price DH, Graña X, Peterlin BM. Fujinaga K, et al. J Virol. 1998 Sep;72(9):7154-9. doi: 10.1128/JVI.72.9.7154-7159.1998. J Virol. 1998. PMID: 9696809 Free PMC article.

4

Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Fujinaga K, Taube R, Wimmer J, Cujec TP, Peterlin BM. Fujinaga K, et al. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1285-90. doi: 10.1073/pnas.96.4.1285. Proc Natl Acad Sci U S A. 1999. PMID: 9990016 Free PMC article.

5

Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.

Wimmer J, Fujinaga K, Taube R, Cujec TP, Zhu Y, Peng J, Price DH, Peterlin BM. Wimmer J, et al. Among authors: fujinaga k. Virology. 1999 Mar 1;255(1):182-9. doi: 10.1006/viro.1998.9589. Virology. 1999. PMID: 10049833 Free article.

6

Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

Taube R, Fujinaga K, Wimmer J, Barboric M, Peterlin BM. Taube R, et al. Among authors: fujinaga k. Virology. 1999 Nov 25;264(2):245-53. doi: 10.1006/viro.1999.9944. Virology. 1999. PMID: 10562489 Free article. Review. No abstract available.

7

Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Taube R, Fujinaga K, Irwin D, Wimmer J, Geyer M, Peterlin BM. Taube R, et al. Among authors: fujinaga k. J Virol. 2000 Jan;74(2):892-8. doi: 10.1128/jvi.74.2.892-898.2000. J Virol. 2000. PMID: 10623752 Free PMC article.

8

Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.

Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM, Price DH. Chao SH, et al. Among authors: fujinaga k. J Biol Chem. 2000 Sep 15;275(37):28345-8. doi: 10.1074/jbc.C000446200. J Biol Chem. 2000. PMID: 10906320 Free article.

9

Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Taube R, Lin X, Irwin D, Fujinaga K, Peterlin BM. Taube R, et al. Among authors: fujinaga k. Mol Cell Biol. 2002 Jan;22(1):321-31. doi: 10.1128/MCB.22.1.321-331.2002. Mol Cell Biol. 2002. PMID: 11739744 Free PMC article.

10

Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.

Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL. Lind KE, et al. Among authors: fujinaga k. Chem Biol. 2002 Feb;9(2):185-93. doi: 10.1016/s1074-5521(02)00106-0. Chem Biol. 2002. PMID: 11880033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters